Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy.

[1]  F. Milord,et al.  Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness , 1992, The Lancet.

[2]  F. Meurice,et al.  High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  F. Meurice,et al.  An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  J. Pépin,et al.  TRIAL OF PREDNISOLONE FOR PREVENTION OF MELARSOPROL-INDUCED ENCEPHALOPATHY IN GAMBIENSE SLEEPING SICKNESS , 1989, The Lancet.

[5]  F. Milord,et al.  DIFLUOROMETHYLORNITHINE FOR ARSENO-RESISTANT TRYPANOSOMA BRUCEI GAMBIENSE SLEEPING SICKNESS , 1987, The Lancet.

[6]  D. Al,et al.  Role of antibody in the elimination of trypanosomes after DL-alpha-difluoromethylornithine chemotherapy. , 1983 .

[7]  H. Whittle,et al.  The febrile response to treatment in Gambian sleeping sickness. , 1972, Annals of tropical medicine and parasitology.

[8]  F. Hawking.  Estimation of the concentration of melarsoprol (Mel B) and Mel W in biological fluids by bioassay with trypanosomes in vitro. , 1962, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  E. Friedheim.  Mel B in the treatment of tryparsamide resistant T. gambiense sleeping sickness: observations on drug resistance in the trypanosomes of the French Cameroun. , 1951, The American journal of tropical medicine and hygiene.

[10]  F. Milord,et al.  The treatment of human African trypanosomiasis. , 1994, Advances in parasitology.

[11]  B. Brabin,et al.  Parasitic infections in women and their consequences. , 1992, Advances in parasitology.

[12]  J. Pépin,et al.  African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[13]  D. Smith,et al.  Treatment of Rhodesian sleeping sickness in Kenya. , 1989, Annals of tropical medicine and parasitology.

[14]  F. Jennings.  The potentiation of arsenicals with difluoromethylornithine (DFMO): experimental studies in murine trypanosomiasis. , 1988, Bulletin de la Societe de pathologie exotique et de ses filiales.

[15]  G. Kazyumba.  Sleeping sickness in the Republic of Zaire over the past 25 years (1952-1976). , 1979 .

[16]  J. Ruppol,et al.  [Follow-up study of therapy of trypanosomiasis in Kimpangu (Republic of Zaire)]. , 1977, Annales de la Societe belge de medecine tropicale.

[17]  F. I. Apted.  Four years' experience of melarsen oxide/BAL in the treatment of late-stage Rhodesian sleeping sickness. , 1957, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[18]  R. Baylet,et al.  [Metabolism of melaminyl-4-phenyl-arsenodithioglycerine in propylene glycol solution: its passage into cerebrospinal fluid]. , 1951, Bulletin de la Societe de pathologie exotique et de ses filiales.